Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study

OBJECTIVE: The Qatar Study was designed to examine the efficacy of combination therapy with exenatide plus pioglitazone versus basal/bolus insulin in patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea. RESEARCH DESIGN AND METHODS: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul-Ghani, Muhammad, Migahid, Osama, Megahed, Ayman, Adams, John, Triplitt, Curtis, DeFronzo, Ralph A., Zirie, Mahmoud, Jayyousi, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864032/
https://www.ncbi.nlm.nih.gov/pubmed/28096223
http://dx.doi.org/10.2337/dc16-1738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864032/
https://www.ncbi.nlm.nih.gov/pubmed/28096223
http://dx.doi.org/10.2337/dc16-1738

Ejemplares similares